NSPR — InspireMD Inc
NASDAQ · Healthcare · Medical Devices
$0.90
-$0.01 (-0.94%)
InspireMD Inc (NSPR) is a medical devices company listed on NASDAQ. It is led by Marvin L. Slosman, based in 6303 Waterford District Drive, Miami, FL, United States, 33126, with about 127 employees. InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Latest reported NSPR revenue for 2025-09-30 was $2.5M. Net income was -$12.7M. Revenue was up 41.9% from 2025-06-30 to 2025-09-30. NSPR currently screens at market cap $34.6M.
Use this NSPR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NSPR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NSPR SEC filings page. Lician reads the product cache first so this HTML stays unique to InspireMD Inc even when a live quote feed is slow.
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
NSPR Key Statistics
Market Cap
$34.57M
Volume
4,511
Previous Close
$0.87
Day Range
$0.85 – $0.87
P/B Ratio
0.77
EPS
-$0.76
Revenue
$7.01M
Net Income
-$32.01M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+13.0%
Profit Margin
-456.6%
Employees
127
NSPR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $7.01M | $6.21M | $5.17M | $4.50M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$32.01M | -$19.92M | -$18.49M | -$14.92M |
| EPS (Diluted) | -$0.76 | -$0.82 | -$2.35 | $0.00 |
Total Assets
$46.81M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$18.92M
Operating Cash Flow
-$21.87M
Free Cash Flow
$0.00
InspireMD Inc Company Information
- President, CEO & Director
- Marvin L. Slosman
- Headquarters
- 6303 Waterford District Drive, Miami, FL, United States, 33126
- Website
- www.inspiremd.com
- Phone
- 888 776 6804
- IPO / Founded
- 2011-04-12
- Sector
- Healthcare
- Industry
- Medical Devices